ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 267

Musculoskeletal Ultrasound As a Diagnostic Tool for Eosinophilic Fasciitis and Correlation with MRI Findings

Florentina Berianu1, Neha Narula2 and Andy Abril1, 1Rheumatology, Mayo Clinic Florida, Jacksonville, FL, 2Division of Rheumatology, Mayo Clinic, Jacksonville, FL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Eosinophilic Fasciitis (Shulman's Disease), MRI and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Eosinophilic fasciitis (EF) presents with pain and induration of the skin. Currently the clinical diagnosis is based on typical physical findings along with MRI enhancement of the fascia, and the diagnosis is confirmed by documenting fascial thickening and inflammation on tissue histology, including eosinophilic infiltrates. A recent case report has suggested fascia thickness can be measured with use of MSK ultrasound. Changes in compressibility of subcutaneous tissue using a high-frequency probe have been shown to help distinguish it from scleroderma patients. Objective: To describe a cohort of 7 patients with MSK US finding supporting the diagnosis of eosinophilic fasciitis with corresponding MRIs findings compared with normal controls.

Methods: 7 patients with suspected EF seen in our rheumatology clinic underwent MSK US of upper or lower extremities that exhibited findings of induration suggestive of EF. An ultrasound was performed using a 12-18 MHZ linear array transducer to visualize muscle and fascia in the area of pain and induration. A measurement of fascial thickness was recorded in all patients. MSK US was also performed in 7 healthy controls. Patients subsequently underwent MRI of the same region. Full thickness skin to muscle biopsy to confirm the diagnosis was performed in 6 out of 7 cases (one patient refused biopsy). Initial labs with serum eosinophils were recorded. None of the patients had Raynaud’s or showed clinical or laboratory findings of scleroderma.

Results: 4 females and 3 males were included. Mean age: 43.5. Absolute eosinophil values ranged from 1051-4780/microL. The mean thickness of the fascia was 0.43 cm (ranges 0.21-0.7 cm) versus 0.14 cm in normal controls (ranges: 0.11-0. 19 cm). All patients had MRI with contrast with evidence of thickened and enhanced fascia of the same region. Diagnosis of EF was confirmed with tissue histology in all cases in which biopsy was performed.

Conclusion: MSK US may represent a quick, safe, inexpensive and reliable diagnostic method for patient with suspected EF. It can also help locate the best site for biopsy.


Disclosure: F. Berianu, None; N. Narula, None; A. Abril, None.

To cite this abstract in AMA style:

Berianu F, Narula N, Abril A. Musculoskeletal Ultrasound As a Diagnostic Tool for Eosinophilic Fasciitis and Correlation with MRI Findings [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/musculoskeletal-ultrasound-as-a-diagnostic-tool-for-eosinophilic-fasciitis-and-correlation-with-mri-findings/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-ultrasound-as-a-diagnostic-tool-for-eosinophilic-fasciitis-and-correlation-with-mri-findings/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology